Clinical Trial Update: Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study assesses the mass balance and pharmacokinetics of the TAS-102 components trifluridine and tipiracil in patients with advanced solid tumors; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED